THE ROLE OF ANTINUCLEAR ANTIBODIES TOGETHER WITH SOME OTHER SEROLOGICAL PARAMETERS AS BIOMARKERS OF CARDIOVASCULAR MORBIDITY IN PATIENTS WITH END STAGE RENAL DISEASE.CASE CONTROL STUDY